GGrantIndex
Sort

34,240 grants matching atherosclerosis

Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade

$641,386
Garret A Fitzgerald · University Of Pennsylvania · R01 · FY2019 · HL

Cardiovascular Evaluation for the SHS Phase V

$641,335
Richard B Devereux · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · HL

IN VIVO FUNCTIONS OF ADHESION AND SIGNALING MOLECULES

$641,277
Rodger Paul McEver · Oklahoma Medical Research Foundation · P01 · FY2010 · HL

Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease

$641,276
Rheem Angela Totah · University Of Washington · R01 · FY2024 · HL

Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine

$641,184
Gregory M Lanza · Washington University · R01 · FY2013 · HL

Endovascular Devices and Vascular Repair

$641,174
Elazer R Edelman · Massachusetts Institute Of Technology · R01 · FY2017 · GM

Functional Interactions Between Lipoproteins and Protease Inhibitors in Atherosclerosis

$641,168
Scott M Gordon · University Of Kentucky · R01 · FY2024 · HL

Epigenetics of Arteriosclerosis in African American Hypertensive Sibships

$641,123
Jennifer Ann Smith · University Of Michigan At Ann Arbor · R01 · FY2017 · HL

Innovative Multigenerational Household Intervention to Reduce Stroke and CVD

$641,110
Dedra S Buchwald · University Of Washington · R01 · FY2014 · HL

Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease

$641,097
Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2019 · HL

Hopkins Lupus Cohort

$641,036
Michelle A Petri · Johns Hopkins University · R01 · FY2012 · AR

Inflammation, Innate Immunity and Thrombosis

$641,023
Jane E Freedman · Boston University Medical Campus · P50 · FY2007 · HL

Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults

$640,990
Morgan Erika Grams · New York University School Of Medicine · R01 · FY2024 · DK

Lipid raft therapy – a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities

$640,876
Michael Ilya Bukrinsky · George Washington University · R01 · FY2022 · HL

Cholesterol Regulation of Endothelial K+ Channels

$640,746
Irena Levitan · University Of Illinois At Chicago · R01 · FY2024 · HL

Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis

$640,741
Babak Razani · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

Mechanisms of Depression in CVD

$640,717
James Douglas Bremner · Emory University · R01 · FY2009 · HL

Stroke and aPL: Community-Based Clinicopathological Study

$640,687
Steven R Levine · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · HL

Subclinical Atherosclerosis in HIV plus Black Cocaine Users

$640,671
Shenghan Lai · Johns Hopkins University · R01 · FY2014 · DA

Heart Disease in Rheumatoid Arthritis

$640,546
Sherine E Gabriel · Mayo Clinic Rochester · R01 · FY2006 · AR

Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users

$640,538
Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2023 · ES

Novel genetic Insight into the molecular pathogenesis of atherosclerosis

$640,457
Dianna M Milewicz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · HL

Novel genetic Insight into the molecular pathogenesis of atherosclerosis

$640,457
Dianna M Milewicz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · HL

Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation

$640,365
Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2014 · AI

The Relevance of Arterial Stiffness and Vascular Calcium to Blood Pressure and LV Structure and Function.

$640,348
Matthew A Allison · University Of California, San Diego · R01 · FY2020 · HL